Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

A new general medical journal for the 21st centrury, focusing on innovation in health and medical research

Latest Submissions Open for Peer Review

A new feature on the JMIR website, open peer review articles, allows JMIR users to sign themselves up as peer reviewers for specific articles currently considered by the Journal (in addition to author- and editor-selected reviewers). The list below shows recently submitted articles where submitting authors have not opted-out of the open peer-review experiment and where the editor has not made a decision yet. (Note that this feature is for reviewing specific articles - if you just want to sign up as reviewer (and wait for the editor to contact you if articles match your interests), please sign up as reviewer using your profile).
To assign yourself to an article as reviewer, you must have a user account on this site (if you don't have one, register for a free account here) and be logged in (please verify that your email address in your profile is correct). Add yourself as a peer reviewer to any article by clicking the '+Peer-review Me!+' link under each article. Full instructions on how to complete your review will be sent to you via email shortly after. Do not sign up as peer-reviewer if you have any conflicts of interest (note that we will treat any attempts by authors to sign up as reviewer under a false identity as scientific misconduct and reserve the right to promptly reject the article and inform the host institution).
The standard turnaround time for reviews is currently 2 weeks, and the general aim is to give constructive feedback to the authors and/or to prevent publication of uninteresting or fatally flawed articles. Reviewers will be acknowledged by name if the article is published, but remain anonymous if the article is declined.

The abstracts on this page are unpublished studies - please do not cite them (yet). If you wish to cite them/wish to see them published, write your opinion in the form of a peer-review!

Tip: Include the RSS feed of the JMIR submissions on this page on your iGoogle homepage, blog, or desktop RSS reader to stay informed about current submissions!

JMIR Submissions under Open Peer Review

↑ Grab this Headline Animator


If you follow us on Twitter, we will also announce new submissions under open peer-review there.


Titles/Abstracts of Articles Currently Open for Review


Titles/Abstracts of Articles Currently Open for Review:

  • Mothers’ Willingness to Share Personal Health Data with Researchers: Survey Results from an Opt-in Panel

    Date Submitted: Mar 19, 2019
    Open Peer Review Period: Mar 22, 2019 - May 17, 2019

    Background: The advances in information communication technology have allowed researchers to collect data continuously through mobile sources on the targeted populations. However, research has shown that different population exhibit different data sharing preferences. Socioeconomic status, type, and source of devices used to collect these data are all factors that shape these preferences. Objective: In this study, we aim to assess women, in particular, white mothers’, data sharing preferences. Methods: We used a cross-sectional sample of white mothers (N=622) of healthy children. We administered an online survey questionnaire consisting of 51 questions, of which we selected 15 questions for further analysis. These questions pertain to the attitudes and belief in data sharing, internet use and interest in future research, and sociodemographic and health questions on caregivers and their children. Results: The results showed that mothers preferred to keep their data anonymous (70%) and use patient portals (63%). However, mothers were less willing to share their medical record data (36%) and their GPS location with researchers (40%), whereas, the majority of these mothers were more willing to share their data provided through online surveys (81%) or collected through their mobile phone (68%). Mothers’ motivations and concerns regarding sharing their data were statistically associated with their preferences to keep their data anonymous, use of patient portals, and their willingness-to-share their data with researchers. Conclusions: Our findings suggest that mothers’ concerns outweighed more on their decision to share their patient health data. We also found that mothers’ access and use of a patient portal did not necessarily translate into their willingness to disclose their medical record data. In fact, the majority of these mothers were concerned about sharing their medical record and GPS location data.

  • Using Virtual Reality to Improve Antiretroviral Therapy Adherence in the Treatment of HIV

    Date Submitted: Feb 14, 2019
    Open Peer Review Period: Feb 19, 2019 - Apr 16, 2019

    Background: Nonadherence to HIV medications is a serious unsolved problem and is a major cause of morbidity and mortality in the HIV-positive population. Although treatment efficacy is high if compliance is greater than 90%, about 40% of people with HIV do not meet this threshold. Objective: We tested a novel approach to improve medication adherence by using a low-cost virtual reality (VR) experience to educate people with HIV about their illness. We hypothesized that people with HIV would be more likely to be compliant with the treatment following the 7-minute presentation, and therefore should have decreasing viral loads and improved adherence questionnaire scores. Methods: We showed the VR experience to 107 participants with HIV at a county hospital in Los Angeles, California. Participants completed a validated medication adherence questionnaire (MAQ) before and at least two weeks after the VR experience. We also compared viral loads (VL) and cluster of differentiation 4 (CD4) counts before and on average 101 days after the experience. VL were obtained per the clinic’s standard care protocol. Paired t-tests were performed on the initial and follow-up MAQs, VL, and CD4 counts. To reduce the possibility that VL were trending down regardless of the VR experience, two serial VL obtained prior to the experience were also compared and analyzed. Immediately following the VR experience, participants were given a four-question Likert scale questionnaire that assessed their opinions about the experience. Results: MAQ scores improved from pre- to post- experience with high significance (P = .0001). VL decreased from pre- to post- experience by 0.38 log10 copies/mL (95% CI 0.06 to 0.70; P = .01). In contrast, the two serial VL obtained prior to the experience showed no statistically significant changes. There were no statistically significant changes to CD4 counts. Analysis of the postexperience questionnaire revealed that VR was comfortable for most participants, and that most participants believed the experience to be educational and that it would improve their medication adherence. Conclusions: The findings suggest that the low-cost VR experience caused an increased rate of antiretroviral therapy adherence that resulted in a decrease of VL. Further studies are required to test whether these results are generalizable to other treatment settings and populations.